Five years ago, a group of high-risk skin cancer patients received a bespoke vaccine. The data is finally in, and the results ...
HAMILTON, BERMUDA / ACCESS Newswire / January 23, 2026 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and commercializing nucleic acid deli ...
HAMILTON, BERMUDA / / January 23, 2026 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company ...
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine - which designs nanotechnology-based platforms for clinical translation across specialties - developed a ...
An international team of scientists has designed a new type of therapy to target the mutant toxic RNA that causes myotonic ...
Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with ...
Moderna stock rose over 7% after the company and Merck said their personalized melanoma vaccine kept working at five years, cutting recurrence or death risk by 49%.
In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...
“It’s been known for a long time that obesity causes uncontrolled inflammation, but no one knew the mechanism behind it. Our ...
The Daily Galaxy on MSN
Main cause of sunburn finally revealed, and it’s not the reason we’ve always believed
Scientific consensus on the biological mechanisms underpinning sunburn has remained largely unchanged for decades. The ...
The experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results